PlainRecalls
FDA Drug Moderate Class II Terminated

Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1111-2022

Product Description

Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
1 carton/9 blister packs
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 1 carton/9 blister packs.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1111-2022.